EMILY
MULLIN
WIRED
+ A New Startup Wants to Edit Human Embryos
+ There’s Neuralink—and There’s the Company That Might Surpass It
+ Patients Are Left With Few Options as GLP-1 Copycats Disappear
+ Sperm Stem Cells Were Used for the First Time in an Attempt to Restore Fertility
+ The World’s First CRISPR Drug Gets a Slow Start
+ Here Come the Glow-in-the-Dark Houseplants
Medium
+ The Search for One Vaccine to Rule Them All
+ The Race to Recreate Breast Milk Without the Breast
+ The Era of DNA Database Hacks Is Here
+ Scientists Dodge FDA to Offer a $1 Million Anti-Aging Treatment in South America
+ The Plan to Build Radiation-Proof CRISPR Soldiers
MIT Technology Review
+ Gene Therapy Is Saving Children’s Lives — But Screening to Discover Who Needs It Is Lagging Behind
+ AI Can Spot Signs of Alzheimer’s Before Your Family Does
+ Biohackers Disregard FDA Warning on DIY Gene Therapy
+ The Fertility Doctor Trying to Commercialize Three-Parent Babies
+ A Year After Approval, a Gene-Therapy Cure Gets Its First Customer
Elsewhere
+ For Some COVID Patients, Lung Transplants Are the Best Chance at Survival (Pittsburgh-Post Gazette)
+ Pig Brain Cells May Have Cured a Sea Lion's Epilepsy—Are Humans Next? (National Geographic)
+ Everything You Need to Know About Blood Tests During Pregnancy (New York Times)
+ Patient Advocates and Scientists Launch Push to Lift Ban on ‘3-Parent IVF’ (STAT)
+ Dissecting Brains to Find the Biological Answers to Mental Illness (Washington Post)
+ IVF Often Doesn’t Work. Could an Algorithm Help? (Wall Street Journal)
+ First Baby Monkey Born Using Sperm from Frozen, Immature Testicles (Scientific American)
+ Should You Send Your Kid's DNA to 23andMe? (Washington Post)